Prof. Dr. Martina Cornel is a Physician and Epidemiologist and a Professor of Community Genetics and Public Health Genomics at the Amsterdam University Medical Center. She obtained her M.D. and Ph.D. from Rijksuniversiteit Groningen in 1984 and 1994, respectively. Since 2001, she has been working at Amsterdam University Medical Center at the section Community Genetics and Public Health Genomics in the Department of Human Genetics. She has mainly worked on the responsible implementation of genetic testing and screening. Her research interests include health research, policy advice and neonatal screening. She is a member of the Netherlands Health Council and two of its standing Committees (Population Screening and Council Group). She is also the chair of The Netherlands Program Committee Neonatal Heelprick Screening.

N/A

N/A

Dr Tessel Rigter is a researcher at the Department of Human Genetics, Amsterdam UMC. She completed her Ph.D. studies in "Translating the dynamics of genetics into health care practice" in 2014, at the VU University in Amsterdam. She is currently leading a project on direct-to-consumer genetic testing and is involved on several other projects studying stakeholder perspectives in innovation in genetics and (public) healthcare. She is also program leader of the Personalized Medicine program for the Amsterdam Public Health (APH) research institute, member of the board of the Dutch Asscociation for Community Genetics and Public Health Genomics (NACGG) and works part-time for the National Institute for Public Health and the Environment (RIVM).

Prof. Dr. Lidewij Henneman is a Professor of Patient Perspectives on Genetic Testing at the Department of Human Genetics, Amsterdam UMC. She is also the director of the Amsterdam Reproduction and Development Research Institute and head of the section Community Genetics and Public Health Genomics. She graduated cum laude from Maastricht University in 1995, majoring in Health Sciences, and obtained her Ph.D. from Vrije Universiteit Amsterdam in 2002. Prof. Dr. Henneman’s research interests focus on the impact of applications of new genetic technologies before, during and after pregnancy on individuals and society. Together with her research team, she investigates the perspectives and decisions of (potential) users to help align responsible implementation of applications with community needs, employing both qualitative and quantitative research methodologies. She is also a board member of the Dutch Non-Invasive Prenatal Test (NIPT) Consortium and coordinates research on women’s perspectives (TRIDENT studies), receiving the ZonMw Parel in 2023. She won the Societal Impact Award 2016 (topic NIPT), and received the Dutch Public Health Award (Volksgezondheidsprijs) for her Ph.D. thesis on preconception cystic fibrosis carrier screening.